Overexpression of long non-coding RNA MCM3AP-AS1 in breast cancer tissues compared to adjacent non-tumour tissues

References

• International Agency for Research on Cancer. GLOBOCAN, World Health Organization; [cited 2020 Jun 23]. Available from: http://gco.iarc.fr/today/fact-sheets-cancers/20-Breast-fact-sheet
   Google Scholar
• Akram M, Iqbal M, Daniyal M, et al. Awareness and current knowledge of breast cancer. Biol Res. 2017;50:33.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhao Z, Zh Y, et al. Risk factors and preventions of breast cancer. Int J Biol Sci. 2017;13:1387–1397.
   PubMed Web of Science ®Google Scholar
• Nindrea R, Aryandono T, Lazuardi L. Breast cancer risk from modifiable and non-modifiable risk factors among women in southeast asia: a meta-analysis. Asian Pac J Cancer Prev. 2017;18:3201–3206.
   PubMedGoogle Scholar
• Cava C, Bertoli G, Castiglioni I. Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential. BMC Syst Biol. 2015;9:62.
   PubMed Web of Science ®Google Scholar
• Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011;121:3786–3788.
   PubMed Web of Science ®Google Scholar
• Bin X, Hongjian Y, Xiping Z, et al. Research progresses in roles of LncRNA and its relationships with breast cancer. Cancer Cell Int. 2018;18:179.
   PubMed Web of Science ®Google Scholar
• Kazemzadeh M, Safaralizadeh R, Orang AV. LncRNAs: emerging players in gene regulation and disease pathogenesis. J Genet. 2015;94:771–784.
   PubMed Web of Science ®Google Scholar
• Wu Y, Shao A, Wang L, et al. The role of lncRNAs in the distant metastasis of breast cancer. Front Oncol. 2019;9:407.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sharma S, Watabe K. Roles of lncRNA in breast cancer. Front Biosci (Schol Ed). 2015;7:94–108.
   PubMedGoogle Scholar
• Ye N, Wang B, ZF Q, et al. Functional roles of long non-coding RNA in human breast cancer. Asian Pac J Cancer Prev. 2014;15:5993–5997.
   PubMedGoogle Scholar
• Dastmalchi N, Safaralizadeh R, Miri Nargesi M. LncRNAs: potential novel prognostic and diagnostic biomarkers in colorectal cancer. Curr Med Chem. 2019;26. DOI:10.2174/0929867326666190227230024.
   Web of Science ®Google Scholar
• Mohammadrezakhani H, Baradaran B, Shanehbandi D, et al. Overexpression and clinicopathological correlation of long noncoding RNA TMPO-AS1 in colorectal cancer patients. J Gastrointest Cancer. 2019. DOI:10.1007/s12029-019-00333-7.
   Web of Science ®Google Scholar
• Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10:925–933.
   PubMed Web of Science ®Google Scholar
• Waller P, Blann AD. Non-coding RNAs - A primer for the laboratory scientist. Br J Biomed Sci. 2019;76:157‐65.
   PubMed Web of Science ®Google Scholar
• Ashkavandi ZJ, Najvani AD, AA T, et al. MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumours. Asian Pac J Cancer Prev. 2013;14:3479–3482.
   PubMedGoogle Scholar
• Takei Y, Assenberg M, Tsujimoto G, et al. The MCM3 acetylase MCM3AP inhibits initiation, but not elongation, of DNA replication via interaction with MCM3. J Biol Chem. 2002;277:43121–43125.
   PubMed Web of Science ®Google Scholar
• Li J, Deng M, Wei Q, et al. Phosphorylation of MCM3 protein by cyclinE/cyclin-dependent kinase2 (Cdk2) regulates its function in cell cycle. J Biol Chem. 2011;286:39776–39785.
   PubMedGoogle Scholar
• Yang C, Zhen J, Xue Y, et al. The effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 axis regulating glioblastoma angiogenesis. Front Mol Neurosci. 2018;10:437.
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang P, Sh N, et al. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Oncotarget. 2016;7:41737–41747.
   PubMed Web of Science ®Google Scholar
• Amorim M, Salta S, Henrique R, et al. Decoding the usefulness of non-coding RNAs as breast cancer markers. J Transl Med. 2016;14:265.
   PubMed Web of Science ®Google Scholar
• Lo PK, Wolfson B, Zhou X, et al. Noncoding RNAs in breast cancer. Brief Funct Genomics. 2016;15:200–221.
   PubMed Web of Science ®Google Scholar
• Dastmalchi N, Khojasteh SMB, MM N, et al. The correlation between lncRNAs and helicobacter pylori in gastric cancer. Pathog Dis. 2019;77:9.
   Web of Science ®Google Scholar
• Kazemzadeh M, Safaralizadeh R, MA F, et al. LOC100287225, novel long intergenic non-coding RNA, misregulates in colorectal cancer. Cancer Biomark. 2016;16:499–505.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang L, Chen T, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer. 2019;18:28.
   PubMed Web of Science ®Google Scholar
• Liang M, Jia J, Chen L, et al. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer. Endocrine. 2019;65:318–326.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Shi L, Ch Z, et al. Long non-coding RNA MCM3AP-AS1 inhibits cell viability and promotes apoptosis in ovarian cancer cells by targeting miR-28-5p. Int J Clin Exp Med. 2019;12:2939–2951.
   Web of Science ®Google Scholar
• Gao Y, Zhao H, LncRNA LY. MCM3AP-AS1 regulates miR-1423p/HMGB1 to promote LPS-induced chondrocyte apoptosis. BMC Musculoskelet Disord. 2019;20:605.
   PubMed Web of Science ®Google Scholar
• Xu S, Kong D, Chen Q, et al. Oncogenic long noncoding RNA landscape in breast cancer. Mol Cancer. 2017;16:129.
   PubMed Web of Science ®Google Scholar
• Chen Q, Xu H, Zhu J,, et al. LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis. Biomed Pharmacother. 2020;128:110289.
   Web of Science ®Google Scholar